EC M&A

EC Mergers & Acquisitions advised Equflow on its Sale to Saint-Gobain Life Sciences

Retrieved on: 
Friday, September 24, 2021
Biotechnology, Solution, M&A, Compagnie Française d'Assurance pour le Commerce Extérieur, Saint-Gobain, Mark (given name), Sale, List of life sciences, EC, Measure (mathematics), Health, Company, Mergers and acquisitions, Substance-related disorder, Technology, Industry, Fine chemical

NEW YORK, Sept. 24, 2021 /PRNewswire/ -- EC Mergers & Acquisitions ("EC M&A") is pleased to confirm the sale of Equflow to Saint-Gobain Life Sciences.

Key Points: 
  • NEW YORK, Sept. 24, 2021 /PRNewswire/ -- EC Mergers & Acquisitions ("EC M&A") is pleased to confirm the sale of Equflow to Saint-Gobain Life Sciences.
  • EC M&A acted as the exclusive financial advisor to Equflow on this transaction.
  • Equflow B.V. is the global technology leader in single-use flowmeters and a first mover in the rapidly growing biotechnology & pharma market.
  • EC M&A is a premier middle-market advisory firm, having advised on over 300 completed life sciences and industrial technologies transactions.